In 2015, Tara was diagnosed with melanoma, swiftly progressing to stage 4 with tumors in her neck and brain. Immunotherapy led to remission in 2019 after 36 months of treatment. Tara, now tumor-free, is excited to tell the world about #Immune2Cancer Day.
Tara’s #Immune2Cancer Message
Stay up to date
Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.
